These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Ghrelin in human medullary thyroid carcinomas. Morpurgo PS, Cappiello V, Verga U, Vicentini L, Vaghi I, Lauri E, Nebuloni M, Beck-Peccoz P, Spada A. Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236 [Abstract] [Full Text] [Related]
27. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Laure Giraudet A, Al Ghulzan A, Aupérin A, Leboulleux S, Chehboun A, Troalen F, Dromain C, Lumbroso J, Baudin E, Schlumberger M. Eur J Endocrinol; 2008 Feb; 158(2):239-46. PubMed ID: 18230832 [Abstract] [Full Text] [Related]
28. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF. World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469 [Abstract] [Full Text] [Related]
31. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits. Pelizzo MR, Torresan F, Da Roit A, Merante Boschin I, Chondrogiannis S, Rampin L, Colletti PM, Vinjamury S, Perkins AJ, Rubello D. Rev Esp Med Nucl Imagen Mol; 2015 Aug; 34(6):378-82. PubMed ID: 26420439 [Abstract] [Full Text] [Related]
32. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Machens A, Ukkat J, Hauptmann S, Dralle H. Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055 [Abstract] [Full Text] [Related]
33. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a. Heizmann O, Haecker FM, Zumsteg U, Müller B, Oberholzer M, Oertli D. Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365 [Abstract] [Full Text] [Related]